Detalles de la búsqueda
1.
DNA damage repair kinase DNA-PK and cGAS synergize to induce cancer-related inflammation in glioblastoma.
EMBO J;
42(7): e111961, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36574362
2.
Multiplexed-Based Assessment of DNA Damage Response to Chemotherapies Using Cell Imaging Cytometry.
Int J Mol Sci;
23(10)2022 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35628514
3.
Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatment.
BMC Cancer;
18(1): 812, 2018 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30103709
4.
FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance.
Mol Cancer;
14: 92, 2015 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25928015
5.
Efficacy of a physiotherapy, yoga and patient education programme for patients with breast cancer and hormone therapy-induced pain: a multicentre randomised study protocol (SKYPE 2).
BMJ Open;
14(1): e075378, 2024 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38191246
6.
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts.
Nucleic Acids Res;
38(18): 6159-75, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20494973
7.
Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells.
PLoS One;
17(9): e0274390, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36103569
8.
New Topoisomerase I mutations are associated with resistance to camptothecin.
Mol Cancer;
10: 64, 2011 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-21619602
9.
Internalization of Foldamer-Based DNA Mimics through a Site-Specific Antibody Conjugate to Target HER2-Positive Cancer Cells.
Pharmaceuticals (Basel);
14(7)2021 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34203395
10.
Cyclophilin A as negative regulator of apoptosis by sequestering cytochrome c.
Biochem Biophys Res Commun;
393(2): 325-30, 2010 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-20138823
11.
Claudin gene expression profiles and clinical value in colorectal tumors classified according to their molecular subtype.
Cancer Manag Res;
11: 1337-1348, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30863148
12.
Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (ATR) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer.
Cancer Res;
79(11): 2933-2946, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30987998
13.
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes.
Sci Rep;
9(1): 7665, 2019 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31113981
14.
Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells.
Mol Cancer;
7: 14, 2008 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-18221502
15.
Impact of RNA degradation on gene expression profiles: assessment of different methods to reliably determine RNA quality.
J Biotechnol;
127(4): 549-59, 2007 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16945445
16.
Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients.
Clin Pharmacokinet;
55(9): 1145-57, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27116457
17.
Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis.
Oncotarget;
7(34): 54415-54429, 2016 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27384673
18.
Greatwall promotes cell transformation by hyperactivating AKT in human malignancies.
Elife;
42015 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26613407
19.
Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma.
FEBS Lett;
529(2-3): 232-6, 2002 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-12372606
20.
Detection of anti-p53 antibodies by ELISA using p53 synthetic or phage-displayed peptides.
J Immunol Methods;
259(1-2): 65-75, 2002 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11730842